Previous Article | Next Article 
Journal of Clinical Microbiology, September 2000, p. 3518-3519, Vol. 38, No. 9
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
A Cytotoxin-Producing Strain of Vibrio cholerae
Non-O1, Non-O139 as a Cause of Cholera and Bacteremia after Consumption
of Raw Clams
Hassan
Namdari,1,2,*
Christine
R.
Klaips,2 and
Joan
L.
Hughes1
Clinical Laboratories, Inc.,
Throop,1 and Mercy Hospital, Wilkes
Barre,2 Pennsylvania
Received 23 December 1999/Returned for modification 8 March
2000/Accepted 12 June 2000
 |
ABSTRACT |
We report a case of a cholera-like gastroenteritis subsequent with
bacteremia in a healthy man following consumption of raw clams.
Although we failed to recover the organism from the patient's stool
culture, his blood culture was positive for a non-cholera toxin-producing yet cytotoxin-producing non-O1 and non-O139
Vibrio cholerae.
 |
CASE REPORT |
A healthy 49-year-old man
vacationing with his wife in Ocean City, Md., in mid-July 1998, consumed raw clams at a local restaurant. About 18 h later he
developed severe profuse watery diarrhea, nausea, and vomiting. Over
the next 24 h he was unable to eat or drink and suffered from
constant episodes of nonbloody, watery diarrhea and severe abdominal
cramping and pain. While his wife, who did not eat the raw clams,
remained well, he appeared extremely ill, febrile, and with shaking
chills and was admitted to the hospital due to dehydration and
gastrointestinal pain. On initial examination, his vital signs included
a temperature of 103.3°F, a blood pressure of 140/80 mm Hg, a pulse
of 78 beats/min, and a respiratory rate of 22 breaths/min. His white
blood cell count was 13,200/mm3 with 82% neutrophils. His
low electrolytes included sodium and potassium levels of 137 mmol/liter
and 3.2 mmol/liter, respectively. Blood and stool specimens were
submitted for culture prior to his treatment with intravenous
hydration, suppository acetaminophen, intramuscular prochloroperazine,
and intravenous ciprofloxacin. The patient recovered completely and was
released from the hospital after 48 h.
Microbiological investigations.
Cholera-toxin producing
vibrios, including Vibrio cholerae O1 and O139 serogroups,
which mainly spread through contaminated drinking or recreational
water, cause noninvasive epidemic cholera in developing countries, but
non-O1 V. cholerae may be invasive, transmitted to humans by
ingestion of raw seafood, and cause episodes of systemic bacteremia and
septicemia in patients with underlying medical predisposing conditions,
including malignancies, cirrhosis, and immunodeficiency (6, 11,
12). Because a history of raw seafood consumption by the patient
was not indicated on the laboratory request slip, the stool specimen
received from the patient was processed for common enteric pathogens,
including Salmonella, Shigella, and
Campylobacter species, by inoculation to blood agar,
MacConkey agar, Hektoen enteric agar, and Campy-BAP (Becton
Dickinson Microbiology Systems, Sparks, Md.). Initially, thiosulfate-citrate-bile-sucrose (TCBS) agar was not inoculated. As a
consequence, V. cholerae was not isolated from his stool specimen. Of two sets of blood cultures processed by the BACTEC 9240 system (Becton Dickinson Microbiology Systems), one was positive for a
curved, highly motile gram-negative rod after 48 h. The isolate
was
-hemolytic on sheep blood agar, oxidase positive, fermentative,
and grew on TCBS agar as large raised shiny yellow colonies. It was
identified as V. cholerae biotype 6001010 by using a
MicroScan gram-negative Combo panel (Dade International, Inc.,
Sacramento, Calif.) and was susceptible to
trimethoprim-sulfamethoxazole, ampicillin, cefazolin, gentamicin,
aztreonam, and ciprofloxacin. The isolate was encapsulated, and the
capsular material appeared as faint blue halos around dark purple cells
stained by the Hiss method (2). The identification of the
isolate was later confirmed by the Pennsylvania Department of Health
and Center for Disease Control and Prevention as a non-cholera
toxin-producing, non-O1, non-O139 V. cholerae. The isolate
did not bear the cholera toxin gene (ctxA), which was
confirmed by a PCR reported by the enteric bacteriology section at the
Centers for Disease Control and Prevention.
To account for his watery diarrhea, studies for a cytotoxin were
undertaken. Cytotoxin activity of the culture filtrates of the V. cholerae isolate grown in tryptic soy broth and brain heart infusion broth (Becton Dickinson Microbiology Systems) media were tested on HEp-2 cell monolayers (8). The cell-free filtrate of tryptic soy broth but not brain heart infusion broth showed cytotoxicity at a 1:32 dilution on HEp-2 cells. The cytotoxin activity
of the filtrate was neutralized by the addition of the patient's
serum, derived 6 weeks postinfection, to the HEp-2 cell monolayer prior
to its inoculation with V. cholerae cell culture extract.
However, the hemolytic activity of the strain remained intact when a
blank filter paper disk saturated with the patient's serum was placed
along the line of inoculation on the sheep blood agar.
V. cholerae non-O1 was not detected in the stool specimen of
this patient despite processing of the specimen for the recovery
of
enteric pathogens. TCBS medium, which would have enhanced detection,
was not inoculated simply because the history of consumption of
raw
clams by the patient was not indicated. This case underscores
the
importance of a history of traveling to the coastal regions
and
ingestion of raw seafood by patients, which should be effectively
communicated between the primary physicians and the microbiologists,
when the diarrheal stool specimens are submitted to a
microbiology
laboratory. The patient's admission blood culture
became positive
for a slightly curved gram-negative rod, which was
initially suspected
to be a
Campylobacter or a
Vibrio species. It was subsequently
identified as
V. cholerae by both API 20E and MicroScan gram-negative
Combo
identification systems. The isolate failed to grow on MacConkey
agar,
which also might have contributed to the lack of recovery
of the
organism from the initial-stool specimen. The strain was
a non-cholera
toxin-producing, non-O1, non-O139
V. cholerae which
clinically caused cholera symptoms (
1). On the other hand,
the isolate was encapsulated, beta-hemolytic, and demonstrated
a rather
high titer of cytotoxin activity on a HEp-2 cell monolayer.
Although
our present report cannot fully characterize the hemolytic
and
cytotoxic activities of the strain, it is noteworthy that
only the
cytotoxicity was neutralized by the patient's serum.
Non-cholera
toxigenic strains of both O1 and non-O1 serotypes
of
V. cholerae have been associated with cholera-like symptoms
in humans
(
1,
10). These reports hence strengthen the role
of the
cytotoxin in conjunction with hemolysin, encapsulation,
and any other
potential virulence factor(s) accounting for enteropathogenicity
and
bacteremia in this
patient.
The majority of cases of bacteremia caused by non-O1 serogroups of
V. cholerae have been reported in patients with chronic
underlying medical problems, including cirrhosis, renal failure,
hematological malignancies, and immunodeficiencies (
9). In
contrast, this patient was an active, healthy 49-year-old man,
with no
identifiable underlying conditions, who ingested raw shellfish.
His
bacteremia most probably resulted from the transmural migration
of the
organism through the gastrointestinal tract. Although we
did not
identify the specific serotype of this isolate, it is
possible that
among the 193 currently recognized serotypes of
V. cholerae
(
14), they may individually vary regarding the extent
of
their virulence and pathogenicity. We suggest that while investigators
search for new virulence factors generated by
V. cholerae,
serotyping
of the isolates involved in serious human infections may
indicate
that a particular serotype is associated with invasive
diseases.
To date, there are no published guidelines for antibiotic therapy of
non-O1
V. cholerae infections (
4,
9).
Nonetheless,
this isolate was susceptible to
trimethoprim-sulfamethoxazole,
ampicillin, cefazolin, gentamicin,
aztreonam, and ciprofloxacin
in vitro, and the patient appeared
completely afebrile after 48
h of therapy with intravenous
ciprofloxacin.
Both consumption of raw seafood and exposure of open wounds to salt
water are known to be common mechanisms of transmission
of non-O1
V. cholerae in the United States (
3,
7,
13).
However, this case augments previous findings that clams consumed
in
the United States may harbor
V. cholerae, which can cause
life-threatening
septicemia in individuals with underlying liver
disease (
5).
Therefore, the consumption of raw and
undercooked shellfish should
be considered potentially
hazardous.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Clinical
Laboratories, Inc., 901 Keystone Industrial Park, Throop, PA 18512. Phone: (570) 346-1759. Fax: (570) 941-3588. E-mail:
hnamdari{at}clinical.com.
 |
REFERENCES |
| 1.
|
Bhattacharya, M. K.,
D. Dutta,
S. K. Bhattacharya,
A. Deb,
A. K. Mukhopadhyay,
G. B. Nair,
T. Shimada,
Y. Takeda,
A. Chowdhury, and D. Mahalanabis.
1998.
Association of a disease approximating cholera caused by Vibrio cholerae of serogroups other than O1 and O139.
Epidemiol. Infect.
120:1-5[CrossRef][Medline].
|
| 2.
|
Hendrickson, D. A., and M. M. Krenz.
1991.
Reagents and stains, p. 1289-1313.
In
A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
|
| 3.
|
Hughes, J. M.,
D. G. Hollis,
E. J. Gangarosa, and R. E. Weaver.
1978.
Non-cholera Vibrio infections in the United States: clinical, epidemiologic, and laboratory features.
Ann. Intern. Med.
88:602-606.
|
| 4.
|
Jesudason, M. V.,
A. M. Cherian, and T. J. John.
1993.
Blood stream invasion by Vibrio cholerae O139.
Lancet
342:431-431[Medline].
|
| 5.
|
Kontoyiannis, D. P.,
K. E. Calia,
N. Basgoz, and S. B. Calderwood.
1995.
Primary septicemia caused by Vibrio cholerae non-O1 acquired on Cape Cod Massachusetts.
Clin. Infect. Dis.
21:1330-1333[Medline].
|
| 6.
|
Lin, G. J.,
C. T. Chiu,
D. Y. Lin,
I. S. Sheen, and J. M. Lien.
1996.
Non-O1 Vibrio cholerae bacteremia in patients with cirrhosis: 5-yr experience from a single medical center.
Am. J. Gastroenterol.
91:336-340[Medline].
|
| 7.
|
Morris, J. G., and R. E. Black.
1985.
Cholera and other vibrioses in the United States.
N. Engl. J. Med.
312:345-350.
|
| 8.
|
Namdari, H., and E. J. Bottone.
1990.
Cytotoxin and enterotoxin production as factors delineating enteropathogenicity of Aeromonas caviae.
J. Clin. Microbiol.
28:1796-1798[Abstract/Free Full Text].
|
| 9.
|
Safrin, S.,
G. Morris, Jr.,
M. Adams,
V. Pons,
R. Jacobs, and J. E. Conte, Jr.
1988.
Non-O:1 Vibrio cholerae bacteremia: case report and review.
Rev. Infect. Dis.
10:1012-1017[Medline].
|
| 10.
|
Saha, P. K.,
H. Koley,
A. K. Mukhopadhyay,
S. K. Bhattacharya,
G. B. Nair,
B. S. Ramakrishnan,
S. Krishnan,
T. Takeda, and Y. Takeda.
1996.
Nontoxigenic Vibrio cholerae O1 serotype Inaba biotype El Tor associated with a cluster of cases of cholera in southern India.
J. Clin. Microbiol.
34:1114-1117[Abstract].
|
| 11.
|
Shelton, C. H., III,
R. L. Martino, and K. M. Ramsey.
1993.
Recurrent non-O1 Vibrio cholerae bacteremia in a patient with multiple myeloma.
Cancer
72:105-107[CrossRef][Medline].
|
| 12.
|
Siegel, M. I., and A. I. Roger.
1982.
Fatal non-O1 Vibrio cholerae septicemia in chronic lymphocytic leukemia.
Gastroenterology
106:300-301.
|
| 13.
|
Wilson, R.,
S. Lieb,
A. Roberts,
S. Stryker,
H. Janowski,
R. Gunn,
B. Davis,
C. F. Riddle,
T. Barrett,
J. G. Morris, Jr., and P. A. Blake.
1981.
Non-O group 1 Vibrio cholerae gastroenteritis associated with eating raw oysters.
Am. J. Epidemiol.
114:293-298[Abstract/Free Full Text].
|
| 14.
|
Yamai, S.,
T. Okitsu,
T. Shimada, and Y. Katsube.
1997.
Distribution of serogroups of Vibrio cholerae non-O1 non-O139 with specific reference to their ability to produce cholera toxin and addition of novel serogroups.
Kansenshogaku Zasshi
10:1037-1045.
|
Journal of Clinical Microbiology, September 2000, p. 3518-3519, Vol. 38, No. 9
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Nesper, J., Krai{beta}, A., Schild, S., Bla{beta}, J., Klose, K. E., Bockemuhl, J., Reidl, J.
(2002). Comparative and Genetic Analyses of the Putative Vibrio cholerae Lipopolysaccharide Core Oligosaccharide Biosynthesis (wav) Gene Cluster. Infect. Immun.
70: 2419-2433
[Abstract]
[Full Text]